Auto-immune neutropenia occurring in association with malignant melanoma

Oncology Reports

Volumn 10, Issue 1, 2003, Pages 249-251

  White, J D ^a   MacPherson, I R J ^a   Evans, T R J ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Auto immune neutropenia; Chemotherapy; Melanoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MELANOMA; MIDDLE AGED; NEUTROPENIA; PARANEOPLASTIC SYNDROME; PATHOLOGY;

ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; NEUTROPENIA; PARANEOPLASTIC SYNDROMES;

EID: 1842834693     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.1.249     Document Type: Article

References (8)

1. Heyman MR and Walsh TJ: Autoimmune neutropenia and Hodgkin's disease. Cancer 59: 1903-1905, 1987. (Pubitemid 17072415)
2. Starkebaum G and Arend WP: Neutrophil-binding immunoglobulin G in systemic lupus erythematosus. J Clin Invest 64: 902-912, 1979.
3. Bux J, Kissel K, Nowak K, Spengel U and Mueller-Eckhardt C: Autoimmune neutropenia: clinical and laboratory studies in 143 patients. Ann Hematol 63: 249-252, 1991.
4. Shastri KA and Logue GL: Autoimmune neutropenia. Blood 81: 1984-1995, 1993. (Pubitemid 23106710)
5. Rustagi PK, Han T, Ziolkowski L, Farolino DL, Currie MS and Logue GL: Granulocyte antibodies in leukaemic chronic lymphoproliferative disorders. Br J Haematol 66: 461-465, 1987. (Pubitemid 17146370)
6. Laszlo J, Jones R, Silberman HR and Banks PM: Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients. Arch Intern Med 138: 597-602, 1978. (Pubitemid 9032869)
7. Smith MA and Smith JG: The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia. Curr Opin Hematol 8: 165-169, 2001. (Pubitemid 32324638)
8. Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M and Lundin FE Jr: Non-steroidal anti-inflammatory drugs and neutropenia. Arch Intern Med 153: 2119-2124, 1993.